ABPI salutes GSK online trial data

The Association of the British Pharmaceutical Industry this week welcomed GlaxoSmithKline’s decision to publish the results of all of its clinical trials.

GSK called the planned launch of its Clinical Trial Register (see At A Glance, left) a ‘major advance in providing online access to information’, insisting it had been ‘under development for several months’ and had not been set up in response to controversies over anti-depressant Paxil/Seroxat.

ABPI media relations head Richard Ley said: ‘Anything that increases clinical trial information is welcome.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in